The effect of methadone dose regimen on neonatal abstinence syndrome

Journal of Addiction Medicine

Volumn 9, Issue 2, 2015, Pages 105-110

  McCarthy, John J ^a,b   Leamon, Martin H ^b   Willits, Neil H ^b   Salo, Ruth ^b  

^a Bi Valley Medical Clinic   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

dose regimen; methadone; neonatal abstinence syndrome; pregnancy

Indexed keywords

METHADONE;

ADULT; ADVERSE EFFECTS; DRUG ADMINISTRATION; FEMALE; HUMAN; MALE; NEONATAL ABSTINENCE SYNDROME; NEWBORN; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PREGNANCY; PREGNANCY OUTCOME; PROCEDURES; RETROSPECTIVE STUDY; UNITED STATES; YOUNG ADULT;

ADULT; CALIFORNIA; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INFANT, NEWBORN; MALE; METHADONE; NEONATAL ABSTINENCE SYNDROME; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PREGNANCY; PREGNANCY OUTCOME; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84945128652     PISSN: 19320620     EISSN: 19353227     Source Type: Journal    
DOI: 10.1097/ADM.0000000000000099     Document Type: Article

References (36)

1. Abrahams RR, Kelly SA, Payne S, Rooming-in compared with standard care for newborns of mothers using methadone or heroin. Can Fam Physician 2007; 53 (10): 1722-1730
2. Ballard JL,. Treatment of neonatal abstinence with breast milk containing methadone. J Perinatal Nurs 2002; 15: 76-85
3. Bogen DL, Perel JM, Helsel JC, Pharmacologic evidence to support clinical decision making for peripartum methadone treatment. Psychopharmacology 2013; 225 (2): 441-451
4. Centers for Disease Control and Prevention. QuickStats: mean gestational age, by plurality. United States, 2005. MMWR 2007; 57 (09): 238. Accessed July 17, 2014
5. Centers for Disease Control and Prevention. National Vital Statistics Report: Births: Final Data 2012. http:/www.cdc.gov/nvsr/nvsr62/nvsr62.09. Accessed July 14, 2014
6. Center for Disease Control and Prevention/National Hospital Discharge Survey, 2010. http://www.cdc.gov/nchs/data/nhds/8newsborns/2010new8-numberpercent.pdf. Accessed July 17, 2017
7. Center for Disease Control and Prevention. Breastfeeding data, 2012: http://www.cdc.gov/breastfeeding/data/reportcard/reportcard2012. Updated January 7, 2014. Accessed July 14, 2014
8. Center for Substance Abuse Treatment. Chapter 13: Medication-assisted treatment for opioid addiction during pregnancy. In: Medication-Assisted Treatment for Opioid Addiction in Opioid Treatment Programs. Rockville, MD: Substance Abuse and Mental Health Services Administration (US), 2005. Treatment Improvement Protocol (TIP) Series, No. 43). Available at: http://www.ncbi.nlm.nih.gov/books/NBK64148/
9. Cleary BJ, Donnelly J, Strawbridge J, Methadone dose and neonatal abstinence syndrome-systematic review and meta-analysis. Addiction 2010; 105: 2071-2084
10. Dashe JS, Sheffield JS, Olscher DA, Relationship between maternal methadone dose and neonatal withdrawal. Obstet Gynecol 2002; 100: 1244-1249
11. Dickman L, Isoherranen N,. Quantitative Prediction of CYP2B6 induction by estradiol during pregnancy: potential explanation for increased methadone clearance during pregnancy. Drug Metab Dispos 2013; 41: 270-274
12. Dole V,. Implications of methadone maintenance for theories of narcotic addiction. JAMA 1988; 260: 3025-3029
13. Eap CB, Buclin T, Baumann P,. Interindividual variability of the clinical pharmacokinetics of methadone: implications for the treatment of opioid dependence. Clin Pharmacokinetics 2002; 41 (14): 1153-1193
14. Finnegan LP, Connaughton JF, Kron RE, Neonatal abstinence syndrome: assessment and management. Addict Dis 1975; 2 (1-2): 141-158
15. Gordon AL, Lopatko OV, Stacey H, Patterns of symptom reporting during pregnancy comparing opioid maintained and control women. J Addiction Med 2012: 6 (4): 258-264
16. Handelsman L, Cochrane KJ, Aronson MJ, Two new rating scales for opiate withdrawal. Am J of Alcohol Abuse 1987; 13: 293-308
17. Hayes MJ, Brown MS,. Epidemic of prescription opiate abuse and neonatal abstinence. JAMA 2012; 307 (18): 1974
18. Jansson LJ, DiPietro JA, Velez M, Maternal methadone dosing schedule and fetal neurobehavior. J Matern Fetal Neonatal Med 2009; 22 (1): 29-35
19. Jarvis MA, Wu-Pong S, Kniseley JS, Alterations in methadone metabolism during late pregnancy. J Addict Dis 1999; 18 (4): 51-61
20. Jones HE, Kaltenbach K, Heil SH, Neonatal abstinence syndrome after methadone or buprenorphine exposure. N Engl J Med 2010; 363: 2320-2331
21. Kenner C, Lott JW,. Comprehensive neonatal care: an interdisciplinary approach. Saunders 2007; 426
22. Lichtblau L, Sparber SB,. Opiate withdrawal in utero increases neonatal morbidity in the rat. Science 1981; 212: 943-945
23. McCarthy J,. Intrauterine abstinence syndrome (IAS) during buprenorphine inductions and methadone tapers: Can we assure the safety of the fetus? J Matern-Fetal Neonatal Med 2012; 25 (2): 109-112
24. McCarthy JJ, Leamon MH, Parr MS, High-dose methadone maintenance in pregnancy: maternal and neonatal outcomes. Am J Obstet Gynecol 2005; 193: 606-610
25. Newman RG, Bashkow S, Calko D,. Results of 313 consecutive live births of infants delivered to patients in the New York City methadone maintenance treatment program. Am J Obstet Gynecol 1975; 121 (2): 233-237
26. O'Connor AB, O'Brien L, Alto WA,. Are there gender related differences in neonatal abstinence syndrome following exposure to buprenorphine during pregnancy? J Perinat Med 2013; 41 (5): 621-633
27. Patrick SW, Schumacher RE, Benneyworth BD, Neonatal abstinence syndrome and associated health care expenditures: United States 2000-2009. JAMA 2012; 307 (18): 1934-1940
28. Peles E, Schreiber S, Booch M, Duration of methadone maintenance treatment during pregnancy and pregnancy outcomes in women with opiate addiction. J Addict Med 2012; 6 (1): 18-23
29. Pritham UA, Paul JA, Hayes MJ,. Opioid dependency in pregnancy and length of stay for neonatal abstinence syndrome. J Obstet Gynecol Neonatal Nurs 2012; 41 (2): 180-190
30. Rothwell PE, Gewirtz JC, Thomas MJ,. Episodic withdrawal promotes psychomotor sensitization to morphine. Neuropsychopharmacology 2010; 35: 2579-2589
31. Saiki T, Lee S, Hannam S, Neonatal abstinence syndrome-postnatal ward versus neonatal unit management. Eur J Pediatr 2010; 169 (1): 95-98. doi: 10.1007/s00431-009-0994-
32. Stevenson DK, Sunshine P, Benitz WE,. Fetal and Neonatal Brain Injury. 3rd ed. Cambridge, UK: Cambridge University Press, 2005: 287
33. Swift RM, Dudley M, DePetrillo P, Altered methadone pharmacokinetics in pregnancy: implications for dosing. J Subst Abuse 1989; 1 (4): 453-460
34. Tracy TS, Venkataramanan R, Glover DD, Temporal changes in drug metabolism (CYP1A2, CYP2D6 and CYP3A activity) during pregnancy. Am J Obstet Gynecol 2005; 192 (2): 633-639
35. Unger A, Jagsch R, Bäwert A, Are male neonates more vulnerable to neonatal abstinence syndrome than female neonates? Gend Med 2011; 8 (6): 355-364
36. Whittmann BK, Segal S,. A comparison of the effects of single- and split-dose methadone administration on the fetus: an ultrasound evaluation. Int J Addict 1991; 26 (2): 213-218